Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Bibliografische gegevens
Hoofdauteur:	Paul, Pulock
Andere auteurs:	Azam,Faruque
Formaat:	Thesis
Taal:	English
Gepubliceerd in:	Brac University 2024
Onderwerpen:	Lung cancer Clinical trial Efficacy endpoints Targeted therapy Lungs > Cancer Clinical trials Chemotherapy
Online toegang:	http://hdl.handle.net/10361/23954

Gelijkaardige items

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
door: Rahman, Tasnim
Gepubliceerd in: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
door: Hoque, Ismoth Ara
Gepubliceerd in: (2024)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
door: Karim, Samia Binte
Gepubliceerd in: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
door: Flora, Sanzida Alam
Gepubliceerd in: (2024)

A review on targeted therapies for lung cancer
door: Ashraf, Anushey
Gepubliceerd in: (2023)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
door: Shobnam, Sohana
Gepubliceerd in: (2024)

Molecules associated with the development of lung cancer
door: Rahman, Adree, et al.
Gepubliceerd in: (2023)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
door: Tania, Umme
Gepubliceerd in: (2023)

Protein biomarkers for Lung Cancer: a bioinformatic approach
door: Jeba, Joynob
Gepubliceerd in: (2017)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
door: Bristy, Israt Zerin
Gepubliceerd in: (2021)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
door: Razna, Amrin Islam
Gepubliceerd in: (2019)

Potential of liposomes for the treatment of lung cancer- a review
door: Mim, Shanzida
Gepubliceerd in: (2023)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
door: Zangmo, Thinley
Gepubliceerd in: (2024)

A review on recent advances in drugs for lung cancer treatment
door: Noor, Fouzia
Gepubliceerd in: (2024)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
door: Hasan, Sakib
Gepubliceerd in: (2024)

A systematic review on the efficacy of Fluoxetine in the management of anxiety disorders
door: Akter, Rabia
Gepubliceerd in: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
door: Pial, Sazia Afrin
Gepubliceerd in: (2018)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
door: Shabnam, Musharrat
Gepubliceerd in: (2018)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
door: Das, Reshita
Gepubliceerd in: (2024)

Immunotherapy in the Management of Lung Cancer
door: Tasnim, Humayra
Gepubliceerd in: (2022)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
door: Oishy, Jannatun Noor
Gepubliceerd in: (2024)

Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis
door: Monayem, Kazi Fahim
Gepubliceerd in: (2024)

Lung cancer detection and classification using machine learning
door: Arefin, Mahbubul, et al.
Gepubliceerd in: (2023)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
door: Mukti, Roushney Fatima, et al.
Gepubliceerd in: (2016)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
door: Nandy, Aditi
Gepubliceerd in: (2022)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
door: Abir, Shifaty Nur
Gepubliceerd in: (2024)

The hidden histories of war crimes trials /

A review on drug repurposing for diabetes epidemic
door: Lamia, Sadia Raisa
Gepubliceerd in: (2022)

Update on pharmacological aspects of carotenoids: molecules of pharmaceutical promise
door: Labanna, Marium Akther
Gepubliceerd in: (2022)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
door: Rahman, Sanjida
Gepubliceerd in: (2024)

Changing global policy to deliver safe, equitable, and affordable care for women's cancers
door: Ginsburg, Ophira M., et al.
Gepubliceerd in: (2018)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
door: Raihan, Dilraj
Gepubliceerd in: (2024)

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
door: F. S. Amaral, André, et al.
Gepubliceerd in: (2017)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
door: Nahar, Kamrun
Gepubliceerd in: (2023)

Semantic segmentation with attention dense U-net for lung extraction from X-ray images
door: Auvy, Akib Al Mahmud, et al.
Gepubliceerd in: (2023)

Gene therapy for rare genetic disorders
door: Tanjum, Atia
Gepubliceerd in: (2024)

Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT‑SHOCK trial
door: Robles‑Zurita, Jose Antonio, et al.
Gepubliceerd in: (2022)

Hypothesizing precise cancer treatments based on patient survival using machine learning & deep learning
door: Sakib, Hasibul, et al.
Gepubliceerd in: (2024)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
door: Hossain, Safa Binte
Gepubliceerd in: (2019)

Targeted therapeutic options in the treatment of Breast Cancer
door: Alam, Kazi Tasnuva
Gepubliceerd in: (2022)